Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Your ICD-10 planning starts now!

Hospitals & health networks·2010
Same author

IT challenges in physician practice management.

Hospitals & health networks·2010
Same author

Leaders and values in uncertain times.

Hospitals & health networks·2009
Same author

2009 quest for quality award winners.

Hospitals & health networks·2009
Same author

Physician snapshot.

Hospitals & health networks·2009
Same author

Lessons from the credit crisis.

Hospitals & health networks·2009

Related Experiment Video

Updated: Jun 21, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Pediatric safety.

Lee Ann Runy

    Hospitals & Health Networks
    |July 8, 2009
    PubMed
    Summary

    Pediatric hospitalists address unique child care quality and safety concerns. This review examines four key risk factors in pediatric care settings.

    Area of Science:

    • Pediatric healthcare quality and safety.
    • Hospital-based child care.
    • Risk management in pediatrics.

    Background:

    • Child healthcare presents distinct quality and safety challenges.
    • Effective risk management is crucial for pediatric patient outcomes.
    • Understanding specific risk factors is essential for optimizing care.

    Purpose of the Study:

    • To identify and examine critical risk factors in pediatric care.
    • To evaluate the role and suitability of pediatric hospitalists.
    • To inform decision-making regarding pediatric hospitalist services.

    Main Methods:

    • Review of critical risk factors in pediatric patient care.
    • Analysis of the impact of pediatric hospitalists on quality and safety.

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

  • Assessment of the appropriateness of pediatric hospitalist models.

    • Main Results:

    • Identification of four primary risk factors impacting pediatric care quality.
    • Evaluation of the potential benefits and drawbacks of pediatric hospitalists.
    • Discussion on the alignment of pediatric hospitalist services with patient needs.

    Conclusions:

    • Addressing specific pediatric risk factors is paramount for enhancing care.
    • Pediatric hospitalists offer a potential solution for improving quality and safety.
    • Careful consideration of risk factors is necessary when implementing pediatric hospitalist models.